Safety and Efficacy of Gammaplex® in Idiopathic Thrombocytopenic Purpura (ClinicalTrials.gov - NCT00504075)

BACKGROUND AND OBJECTIVES: This multicentre, open-label study investigated the safety and efficacy of Gammaplex, a 5% Intravenous Immunoglobulin (IVIg), in patients with idiopathic (immune) thrombocytopenic purpura (ITP). MATERIALS AND METHODS: Patients were between the ages of 6 and 70 years; had I...

Descripción completa

Detalles Bibliográficos
Autores principales: Dash, Clive H., Gillanders, Kate R., Stratford Bobbitt, Margaret E., Gascoigne, Ernie W., Leach, Samantha J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043496/
https://www.ncbi.nlm.nih.gov/pubmed/24892422
http://dx.doi.org/10.1371/journal.pone.0096600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043496/
https://www.ncbi.nlm.nih.gov/pubmed/24892422
http://dx.doi.org/10.1371/journal.pone.0096600

Ejemplares similares